Literature DB >> 20427102

Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice.

S Sánchez-Fidalgo1, I Villegas, A Cárdeno, E Talero, M Sánchez-Hidalgo, V Motilva, C Alarcón de la Lastra.   

Abstract

BACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) are at increased risk for developing ulcerative colitis (UC)-associated colorectal cancer (CRC). Several studies have shown that extra virgin olive oil (EVOO) might possess anti-inflammatory, antiproliferative and antiapoptotic effects. We have evaluated EVOO diet effects on the severity of repeated colitis-associated CRC.
METHODS: Six-week-old C57BL/6 mice were randomized into two dietary groups: sunflower oil (SFO) and EVOO diets, both at 10%. Mice were exposed to 15 cycles of 0.7% dextran sodium sulphate (DSS) for 1 week followed by distilled water for 10 days. After, the rats were sacrificed and colonic damage was both histologically and biochemically assessed.
RESULTS: Disease activity index (DAI) was significantly higher on SFO vs. EVOO diet at the end of the experimental period. EVOO-fed mice showed less incidence and multiplicity of tumors than in those SFO-fed mice. β-catenin immunostaining was limited to cell membranes in control groups, whereas translocation from the cell membrane to the cytoplasm and/or nucleus was showed in DSS-treated groups and its expression was higher in SFO-fed animals. Cytokine production was significantly enhanced in SFO-fed mice, while this increase was not significant in EVOO-fed mice. Conversely, cyclooxygenase-2 (COX-2) and inducible nitric oxidase synthase (iNOS) expression were significantly lower in the animal group fed with EVOO than in the SFO group.
CONCLUSIONS: These results confirm that EVOO diet has protective/preventive effect in the UC-associated CRC. This beneficial effect was correlated with a better DAI, a minor number of dysplastic lesions, a lower β-catenin immunoreactivity, a proinflammatory cytokine levels reduction, a non modification of p53 expression and, COX-2 and iNOS reduction in the colonic tissue.
Copyright © 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427102     DOI: 10.1016/j.clnu.2010.03.003

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  18 in total

1.  Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis.

Authors:  María Angeles Rosillo; Marina Sánchez-Hidalgo; Susana Sánchez-Fidalgo; Marina Aparicio-Soto; Isabel Villegas; Catalina Alarcón-de-la-Lastra
Journal:  Eur J Nutr       Date:  2015-02-10       Impact factor: 5.614

2.  Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals.

Authors:  Esmerij P van der Zanden; Francisca W Hilbers; Caroline Verseijden; Rene M van den Wijngaard; Mike Skynner; Kevin Lee; Luis Ulloa; Guy E Boeckxstaens; Wouter J de Jonge
Journal:  Neuroimmunomodulation       Date:  2012-03-21       Impact factor: 2.492

3.  Olive oil prevents benzo(a)pyrene [B(a)P]-induced colon carcinogenesis through altered B(a)P metabolism and decreased oxidative damage in Apc(Min) mouse model.

Authors:  Leah D Banks; Priscilla Amoah; Mohammad S Niaz; Mary K Washington; Samuel E Adunyah; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2015-10-22       Impact factor: 6.048

4.  Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model.

Authors:  Susana Sánchez-Fidalgo; L Sánchez de Ibargüen; A Cárdeno; C Alarcón de la Lastra
Journal:  Eur J Nutr       Date:  2011-08-27       Impact factor: 5.614

5.  Soluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in mice.

Authors:  Wanying Zhang; Haonan Li; Hua Dong; Jie Liao; Bruce D Hammock; Guang-Yu Yang
Journal:  Anticancer Res       Date:  2013-12       Impact factor: 2.480

Review 6.  Dietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitis.

Authors:  Arpit Saxena; Kamaljeet Kaur; Shweta Hegde; Faizan M Kalekhan; Manjeshwar Shrinath Baliga; Raja Fayad
Journal:  J Tradit Complement Med       Date:  2014-10

Review 7.  Review of Anti-Inflammatory Herbal Medicines.

Authors:  Mona Ghasemian; Sina Owlia; Mohammad Bagher Owlia
Journal:  Adv Pharmacol Sci       Date:  2016-05-10

Review 8.  Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.

Authors:  Yusuke Kanda; Mitsuhiko Osaki; Futoshi Okada
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

Review 9.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

10.  Colonic and Hepatic Modulation by Lipoic Acid and/or N-Acetylcysteine Supplementation in Mild Ulcerative Colitis Induced by Dextran Sodium Sulfate in Rats.

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Orlando Roberto Pimentel de Araújo; Valéria Nunes-Souza; Juliana Célia de Farias Santos; Luiza Antas Rabelo; Marília Oliveira Fonseca Goulart
Journal:  Oxid Med Cell Longev       Date:  2016-11-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.